ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
The study aim was to assess the importance of adequate administration of medications with negative chronotropic effect in the improvement of clinical course and prognosis among patients with coronary heart disease (CHD) and heart failure. The possibility and appropriateness of combination therapy wi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/240 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849250389459730432 |
|---|---|
| author | M. G. Glezer E. I. Astashkin I. N. Sokolova |
| author_facet | M. G. Glezer E. I. Astashkin I. N. Sokolova |
| author_sort | M. G. Glezer |
| collection | DOAJ |
| description | The study aim was to assess the importance of adequate administration of medications with negative chronotropic effect in the improvement of clinical course and prognosis among patients with coronary heart disease (CHD) and heart failure. The possibility and appropriateness of combination therapy with β-adrenoblockers (β-AB) and an If channel blocker ivabradine is justified. The authors analyse current real-world trends in the administration and dose titration of these medications among ambulatory Russian patients. Russian doctors need to be more active in the treatment of patients with CHD and heart failure and better understand the need for and benefits of dose titration of medications with negative chronotropic effect, as well as the importance of combination therapy for the improvement of clinical course, prognosis, and quality of life. |
| format | Article |
| id | doaj-art-9540309827fa4d64b91c091d7d64cafb |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2013-10-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-9540309827fa4d64b91c091d7d64cafb2025-08-20T03:57:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-10-01125818610.15829/1728-8800-2013-5-81-86239ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILUREM. G. Glezer0E. I. Astashkin1I. N. Sokolova2I.M. Sechenov First Moscow State Medical University, MoscowI.M. Sechenov First Moscow State Medical University, MoscowI.M. Sechenov First Moscow State Medical University, MoscowThe study aim was to assess the importance of adequate administration of medications with negative chronotropic effect in the improvement of clinical course and prognosis among patients with coronary heart disease (CHD) and heart failure. The possibility and appropriateness of combination therapy with β-adrenoblockers (β-AB) and an If channel blocker ivabradine is justified. The authors analyse current real-world trends in the administration and dose titration of these medications among ambulatory Russian patients. Russian doctors need to be more active in the treatment of patients with CHD and heart failure and better understand the need for and benefits of dose titration of medications with negative chronotropic effect, as well as the importance of combination therapy for the improvement of clinical course, prognosis, and quality of life.https://cardiovascular.elpub.ru/jour/article/view/240coronary heart diseaseheart failureβ-adrenoblockersif channel blockerivabradinecombination therapyprognosisangina |
| spellingShingle | M. G. Glezer E. I. Astashkin I. N. Sokolova ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE Кардиоваскулярная терапия и профилактика coronary heart disease heart failure β-adrenoblockers if channel blocker ivabradine combination therapy prognosis angina |
| title | ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
| title_full | ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
| title_fullStr | ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
| title_full_unstemmed | ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
| title_short | ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE |
| title_sort | role of medications with negative chronotropic effect in the treatment of patients with coronary heart disease and heart failure |
| topic | coronary heart disease heart failure β-adrenoblockers if channel blocker ivabradine combination therapy prognosis angina |
| url | https://cardiovascular.elpub.ru/jour/article/view/240 |
| work_keys_str_mv | AT mgglezer roleofmedicationswithnegativechronotropiceffectinthetreatmentofpatientswithcoronaryheartdiseaseandheartfailure AT eiastashkin roleofmedicationswithnegativechronotropiceffectinthetreatmentofpatientswithcoronaryheartdiseaseandheartfailure AT insokolova roleofmedicationswithnegativechronotropiceffectinthetreatmentofpatientswithcoronaryheartdiseaseandheartfailure |